Lymphoma Clinical Trials in Colorado

Showing 261-280 of 481 trials

Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

NCT02661542

A Phase 1/2a, dose-escalation study of FF-10502-01 in Patients with Advanced Solid Tumors and Lymphomas. A total of up to 9 cohorts will be enrolled in Phase 1 to establish the MTD. Phase 2 will consist of 2 cohorts: Cohort 1 will include subjects with Pancreatic Cancer. Cohort 2 will include subjects with another tumor type enrolled in the Phase 1 dose-escalation phase who have demonstrated Clinical Benefit by Week 16.

Solid TumorsLymphomas

Fujifilm Pharmaceuticals U.S.A., Inc.99 participantsStarted Jan 2016

Denver, Colorado, United States • Houston, Texas, United States

COMPLETEDPhase 1/253 miles

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

The purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers. This study was conducted in 2 phases, Phase 1 and Phase 2.

Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more

Incyte Corporation444 participantsStarted Jul 2014

La Jolla, California, United States • Los Angeles, California, United States • Sacramento, California, United States +21 more locations

Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Lymphoma Trials in Other Cities

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

A Study of LY3023414 in Participants With Advanced Cancer

A Study of PLX2853 in Advanced Malignancies.

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Therapy for Pediatric Hodgkin Lymphoma

Other Conditions in Colorado